ANI PHARMACEUTICALS INC (ANIP:NASDAQ)
$78.51 -2.6 (-3.2055%)
Analysed ANI PHARMACEUTICALS INC (ANIP:NASDAQ) News Sources
ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook Raised
11-05-2026
yahoo.com
Global Alpha Dumps 229,000 Ani Pharmaceuticals (ANIP) Shares Worth $17.9 Million
11-05-2026
fool.com
ANI Pharmaceuticals: Rare Disease Shift and the 2026 Playbook
15-05-2026
yahoo.com
ANI Pharmaceuticals Refocuses On Rare Disease As Buybacks And Insider Sales Rise
17-05-2026
yahoo.com
How Raised 2026 Guidance And A New Buyback At ANI Pharmaceuticals (ANIP) Has Changed Its Investment Story
17-05-2026
yahoo.com
2 Profitable Stocks with Competitive Advantages and 1 Facing Headwinds
18-05-2026
yahoo.com
ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Weaker Than They Seem
19-05-2026
yahoo.com
Q1 Earnings Outperformers: ANI Pharmaceuticals (NASDAQ:ANIP) And The Rest Of The Pharmaceuticals Stocks
21-05-2026
yahoo.com
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
2 Growth Stocks with Explosive Upside and 1 We Avoid
29-05-2026
yahoo.com
What is the current price of ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The current price of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is $78.51.
ANI PHARMACEUTICALS INC (ANIP:NASDAQ) absolute price change since previous trading day?
The absolute price change of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) since the previous trading day is $-2.6.
ANI PHARMACEUTICALS INC (ANIP:NASDAQ) percentage price change since previous trading day?
The percentage price change of ANI PHARMACEUTICALS INC (ANIP:NASDAQ) since the previous trading day is -3.2055%.
What is the most recent average sentiment score for ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The most recent average sentiment score for ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for ANI PHARMACEUTICALS INC (ANIP:NASDAQ)?
The most recent sentiment for ANI PHARMACEUTICALS INC (ANIP:NASDAQ) is .
SEC-8K** Filing Available For ANI PHARMACEUTICALS INC (ANIP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.